Navigation Links
US FDA approved Aurobindo Pharma to produce generic AIDS drug

The US Food and Drug Association (FDA) has approved Aurobindo Pharma Limited to produce the generic version of oral Stavudine solution// 1 mg/mL, which is used in children for control of HIV treatment. Zerit (Stavudine Oral solution) is produced commercially by Bristol-Myers Squibb which has the patent for the drug which is found to be very effective against HIV. Stavudine is a synthetic thymidine nucleoside analogue. The generic version approved for Aurobindo pharma manufacture could be given in HIV treatment to children’s from childhood to adolescent age. The drug Stavudine acts by inhibiting the cell division of the HIV by inhibiting its reverse transcriptase enzyme which is required for the virus replication. Aurobindo Pharmaceuticals is present in India which is involved in the manufacturing of generic and active pharmaceutical drugs.
'"/>




Page: 1

Related medicine news :

1. Abortion Pill approved by FDA
2. Another injectable contraceptive Pill approved by FDA
3. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
4. New oral antiviral treatment of cold sores approved
5. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
6. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
7. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
8. IGF-1 drug approved by FDA
9. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
10. Thalidomide is the new approved drug for treating multiple cancers
11. Tamiflu drug approved in Europe for children’
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... 2016 , ... MEDI+SIGN®, a provider of fully-automated patient monitoring ... for Emergency Departments (ED) has been added to their portfolio. Housed in a ... and with a simplified pallet of information available to the patient, the Digital ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West ... January 1, 2017. The name change aligns the entire company with its ... health care quality. , “We are very proud of the achievements associated with ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation , ... and other pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger ... vice president of sales. , Litsinger joined Mirixa in 2008 after serving ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology: